Research is central to the work of the Freiburg Center for Pediatrics and Adolescent Medicine. Our research strengths represent a wide spectrum of pediatric research. Our basic and translational research stimulates new understandings of disease mechanisms and inspires new approaches to treatment. Through our clinical research we test novel therapies which have been specifically adapted or newly developed to suit the needs of children and young people. And our healthcare research drives improvements that enable delivery of better care for children and their families in a complex and changing environment.
On the Research pages of this site, our leading researchers showcase their work. For more information about the Freiburg Center for Pediatrics and Adolescent Medicine, please visit our pages on the website of the Freiburg University Medical Center.
About the Freiburg Center for Pediatrics and Adolescent Medicine
Over €4.5 million
In 2018, the Freiburg Center for Pediatrics and Adolescent Medicine received over €4.5 million in external funding and grants.
Four Collaborative Research Centers
The Freiburg Center for Pediatrics and Adolescent Medicine participates in four DFG-funded Collaborative Research Centers (SFBs):
Six European Reference Networks
In association with the Freiburg Center for Rare Diseases, we are involved in six of the European Reference Networks for Rare Diseases:
- ERN-BOND for rare bone diseases
- EURO-NMD for rare neuromuscular diseases
- MetabERN for rare hereditary metabolic disorders
- PaedCan-ERN for pediatric cancer/hemato-oncology
- ERN-RITA for rare immunodeficiency, autoinflammatory and autoimmune diseases
- VASCERN for rare multisystemic vascular diseases.
200 publications
In 2018, our researchers were authors on almost 200 scientific publications.
120 clinical trials & registry studies
In 2018, the Freiburg Center for Pediatrics and Adolescent Medicine enrolled participants in over 120 clinical trials and register studies via our Study Office.
Research centers & networks
Researchers from the Freiburg Center for Pediatrics and Adolescent Medicine play a key role in many regional, national and international research centers and graduate colleges, including:
- the German Cancer Research Center (DKTK) and the Comprehensive Cancer Center Freiburg (CCCF)
- the Center for Chronic Immunodeficiency (CCI)
- the PRIMAL Consortium ("Priming Immunity at the Beginning of Life")
- the iMACnet project ("Genetically corrected iPSC-derived macrophages (i-MAC) for innovative gene therapeutic strategies")
- the Spemann Graduate School of Biology and Medicine
Recent News
SARS-CoV-2 in children: preliminary report for Part 1
The Freiburg Center for Pediatrics and Adolescent Medicine, together with the University Hospitals in Heidelberg (study coordination), Tübingen and Ulm, has been investigating the role of children and families in the spread of the [...]
New study: CoV-SARS-2 in children
How many parents and children in Baden-Württemberg have already been infected with the novel coronavirus SARS-CoV-2? The Center for Child and Adolescent Medicine in Freiburg is investigating this question in cooperation with the University Hospitals [...]
Newly published (Groups: Elling (Junior PI), Henneke, Rohr, Topic: Infectious diseases)
Freiburg researchers including Roland Elling, Philipp Henneke and Jan Rohr have recently published an article in the journal PLoS Medicine about infectious diseases in refugee minors in Germany. Congratulations! Janda, A., Eder, K., [...]